Announcement on the progress of the disposal of assets by the holding subsidiary.
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviations: Jianfeng Group Announcement No.: 2019-025
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Progress Announcement on Disposal of Assets by Holding Subsidiaries
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents.
Overview of 1. Disposal of Assets
2018 12 25 , the 10th 8 Board Meeting of Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the Company") passed the "Proposal on Disposal of Assets by Holding Subsidiaries". The Jinhuashan Tourism Economic Zone Management Committee (hereinafter referred to as the "Jinhuashan Economic Management Committee") and the company's holding subsidiary Zhejiang Jianfeng Cement Co., Ltd. (hereinafter referred to as "Jianfeng Cement") signed the "Agreement" to collect the Jianfeng Cement located in Jinhuashan Tourism Economic Zone Management Committee After eliminating backward production capacity, 10 land use rights and other assets, jinhua Mountain Economic Management Committee will compensate the land use right, buildings and structures on the land, seedling greening, etc., with a total compensation of RMB ,11200 . For details, please refer to the Announcement on Disposal of Assets by Holding Subsidiaries' (Pro 2018-032 ) disclosed by the Company on 2018 12 26 .
2018 12 29 , Jianfeng Cement received the first phase of 30% compensation 3360 yuan paid by Jinhua Mountain Economic Management Committee; 2019 3 29 , jianfeng Cement received the second phase 70% compensation 7840 yuan, and Jinhua Mountain Economic Management Committee has paid all compensation to Jianfeng Cement. For details, please refer to the "Progress Announcement on Disposal of Assets by Holding Subsidists" (Pro 2019-006 ) disclosed by the Company on 2019 4 January 2 .
2. Related Progress and Impact on the Company
Recently, Jianfeng Cement learned that the property rights certificates such as real estate and land involved in the disposal of assets have been canceled , has met the income recognition conditions according to the relevant provisions of the Accounting Standards for Enterprises, and has been preliminarily calculated by the Company's Finance Department, the above-mentioned levy compensation matter will increase the income from the disposal of peak cement assets. after deducting taxes, the net profit of peak cement for the current period will increase by about ,7800 yuan. the final amount will be subject to the audit and confirmation results of the accounting firm.
Please pay attention to the investment risk of the majority of investors.
hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
June 26, 2009
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31